Liquid Biopsy for Precision Oncology Summit West Coast leaderboard
  • Friday, November 20, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

SmartLab Exchange Europe 2027 Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 13

Boehringer Ingelheim Expands Rabies Prevention Program in Zimbabwe

Sep 24, 2026
Boehringer Ingelheim has partnered with AWARE Germany e.V. and AWARE Trust Zimbabwe to expand rabies prevention efforts in Tsholotsho District, one of Zimbabwe’s remote rural areas.…
Read More...

Basecamp Research Raises $140M to Advance AI-Designed Medicines

Sep 24, 2026
Basecamp Research has raised $140 million in a Series C financing round to develop its artificial intelligence platform and advance a pipeline of AI-designed medicines toward clinical…
Read More...

AI, Structure Prediction and Advanced Computational Tools Transform RNA Target Discovery

Sep 23, 2026
Computational technologies are reshaping RNA-targeted drug discovery, enabling researchers to identify promising therapeutic targets with greater confidence and efficiency than ever…
Read More...

Novo Nordisk and UNICEF Expand Childhood Obesity Prevention Program

Sep 23, 2026
Novo Nordisk and UNICEF have expanded their global partnership to prevent childhood overweight and obesity, with a new four-year program expected to reach more than 80 million children.…
Read More...

BoomRay Licenses Preclinical Radioligand Asset to Novartis

Sep 23, 2026
Boomray Pharmaceuticals has entered into an exclusive global licensing agreement with Novartis for a preclinical radioligand therapy (RLT) asset being developed for precision oncology.…
Read More...

Made Scientific Acquires Pennsylvania Cell Therapy Manufacturing Facility

Sep 22, 2026
Made Scientific has acquired an 85,000-square-foot cell therapy manufacturing facility in East Norriton, Pennsylvania, from National Resilience as it expands its capacity to support…
Read More...

Merck’s KEYTRUDA QLEX Approved in Japan for Subcutaneous Use

Sep 21, 2026
Merck’s KEYTRUDA QLEX has been approved in Japan for subcutaneous use across all indications currently approved for KEYTRUDA, giving patients another way to receive the cancer…
Read More...

Lilly Breaks Ground on $6.5 Billion Houston Manufacturing Site

Sep 21, 2026
Eli Lilly and Company has broken ground on a new $6.5 billion pharmaceutical manufacturing site in Houston, Texas, as the company expands its U.S. production capacity for medicines.…
Read More...

Telix to Acquire ITM in $1.65 Billion Radiopharmaceutical Deal

Sep 21, 2026
Telix Pharmaceuticals has agreed to acquire ITM Isotope Technologies Munich in a deal valued at $1.65 billion, bringing together two companies with expertise in radiopharmaceutical…
Read More...

Roche Gets Positive EMA Opinion for Ocrevus in Paediatric MS

Sep 18, 2026
Roche has received a positive recommendation from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for Ocrevus (ocrelizumab) in children and…
Read More...
Previous 1 … 11 12 13 14 15 … 966 Next
Oligonucleotide-based Therapeutics Summit
LEAP HR: Life Sciences Europe
3rd Annual TRP Target Selection & Drug Design Summit
2nd Structure-Based Drug Design Summit San Diego
Liquid Biopsy for Precision Oncology Summit West Coast
2nd Non-Opioid Pain Therapeutics Summit
Muscular Disorders Drug Development Summit
Amylin-Based Therapeutics Summit
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Antigen-Specific Immune Tolerance Summit
7th Operationalize Expanded Access Programs Summit
Viral Vector Process Development & Manufacturing Summit
SmartLab Exchange Europe 2027
8th RNAi-Based Therapeutics Summit
17th World ADC London
PFS & Injectable Drug Devices Europe
Ophthalmic Drug Delivery Summit
Obesity & Weight Loss Drug Development Summit West
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Biomarker Operations & Biospecimen Management
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • OBI Pharma Signs $2 Billion ADC Deal with Novartis
  • Erasca and Bristol Myers Squibb Partner on Pancreatic Cancer Treatment
  • GSK Wins FDA Approval for Nelkarmi in Advanced Lung Cancer
  • OXB Partners with Aura Biosciences for Phase 3 Cancer Drug Development
  • Skylark Bio Advances Hearing Loss Gene Therapy to Younger Children

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Cell Therapy Safety in Autoimmune Disease

7th Operationalize: Expanded Access Programs Summit East…

As AI and ICH M15 Transform Drug Development, Industry…

Industry Leaders Explore the Future of RNA Therapeutics…

Direct RNA Binding Emerges as a Powerful Approach for…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.